natgillin/translations-raw huggingface dataset:
s • chest pain or persistent and severe cough; irregular or rapid heartbeat; shortness of breath, confusion,
Če se pojavi kateri od naslednjih neželenih učinkov, se nemudoma posvetujte s svojim zdravnikom: lat • bolečine v prsih ali trdovraten in hud kašelj; neredno ali hitro bitje srca; težko dihanje, težava ostati buden, odrevenelost, mravljinci ali bolečina v dlaneh ali stopalih; epileptični napadi (konvulzije); težave z vidom, mišljenjem ali zbranostjo; spremenjeno duševno stanje; up
ori difficulty remaining alert, numbness or tingling sensation or pain in hands or feet; seizure (convulsions); trouble sleeping, thinking or concentrating; altered mental state; suicidal thoughts, suicide attempt, changed behaviour or aggressive behaviour (sometimes directed against others),
samomorilne misli ali poskus samomora, spremenjeno obnašanje ali agresivno obnašanje (včasih odkrito proti drugim), halucinacije; močne želodčne bolečine; črno ali smolnato blato; kri v blatu in seču, huda krvavitev iz nosu; voskasta bledica, visoka raven sladkorja v krvi, zvišana telesna temperatura ali mrzlica, ki nastopi po nekaj tednih zdravljenja, bolečina v spodnjem delu hrbta ali no
uth hallucinations; severe stomach pain; black or tar like stools; blood in stool or urine, severe nosebleed; waxy pallor, high sugar level in blood, fever or chills beginning after a few weeks of treatment, lower back or side pain, difficult urination, problems with your eyes or your eyesight or
Vaš če
ra hearing, loss of hearing, severe or painful reddening or sores on your skin or mucous membrane.
zdravnik bo opravil preiskave krvi, da zagotovi, da je vaše število levkocitov (celice, ki se bojujejo proti okužbi), število eritrocitov (celice z železom za prenos kisika), število trombocitov (celice za strjevanje krvi), on
These may signal serious side effects that may need urgent medical attention.
pa tudi drugi vaši laboratorijski izvidi sprejemljivi.
ge and oxygen) counts, platelets (blood clotting cells) and other laboratory values are at acceptable levels.
Na začetku zdravljenja z zdravilom Viraferon boste lahko imeli gripi podobno reakcijo z zvišano telesno uk
At the beginning of treatment with Viraferon, you may experience a flu-like reaction, with fever, fatigue, lon headache, muscle ache, joint pain and chills/ rigors.
temperaturo, utrujenostjo, glavobolom, mišičnimi bolečinami, bolečinami v sklepih in mrzlico ali tresenjem.
Other side effects that may occur include: no
Drugi neželeni učinki, ki se lahko pojavijo, so: ks
Very commonly reported side effects (at least 1 in every 10 patients): pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, t
Zelo pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 10 bolnikov): bolečine, otekanje in pordelost ali poškodbe kože na mestu injiciranja, izpadanje las, omotica, Lie
insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/ rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, rod
sprememba teka, želodčne ali trebušne bolečine, driska, slabost (siljenje na bruhanje), virusne okužbe, depresija, čustvena nestabilnost, nespečnost, tesnoba, vnetje žrela in bolečine pri požiranju, utrujenost, mrzlica/ tresavica, zvišana telesna temperatura, gripi podobno stanje, splošni občutek neugodja, glavoboli, hujšanje, bruhanje, razdražljivost, šibkost, nihanje razpoloženja, kašelj (včasih hud), težko dihanje, srbenje, suha koža, izpuščaj, nenadne in hude mišične bolečine, sklepne bolečine,
musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
292 mišičnoskeletne bolečine, spremembe izvidov laboratorijskih krvnih preiskav vključno z zmanjšanim številom belih krvničk.
Some children have had a decrease in their rate of growth (height and weight). lp
Pri nekaterih otrocih se je upočasnila rast (telesna višina in masa).
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red na
ie žeja, dehidracija, zvišan krvni tlak, migrene, otekle bezgavke, pordelost, težave z menstruacijo, zmanjšana spolna sla, vaginalne težave, bolečine v dojkah, bolečine v modih, težave z žlezo ščitnico,
gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, i dic
ác pordele dlesni, suha usta, pordela ali vneta usta ali jezik, zobobol ali zobne bolezni, herpes simpleks (vročinske razjede), sprememba okusa, želodčne težave, dispepsija (zgaga), zaprtje, povečanje jeter
problem with your tear ducts, conjunctivitis (“ pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
ist bolečine, težave s solznimi kanalčki, konjunktivitis (“ rdeče oko ”), vznemirjenost, zaspanost, hoja v spanju, vedenjske težave, živčnost, zamašen nos ali izcedek iz nosa, kihanje, hitro dihanje, bleda ali pordela koža, podplutbe, velika občutljivost prstov na rokah in nogah na mraz, težave s kožo ali nohti,
Me
eg psoriaza (novonastala ali poslabšanje obstoječe), povečano potenje, večja potreba po odvajanju urina, drobni tresoči gibi, zmanjšana občutljivost za dotik, artritis.
Rarely reported side effects (at least 1 in every 10,000 patients, but less than 1 in every 1,000 patients): pneumonia
ur Redko opisani neželeni učinki (pri najmanj 1 na vsakih 10. 000 bolnikov, vendar manj kot 1 na vsakih 1. 000 bolnikov): pljučnica
Very rarely reported side effects (less than 1 in every 10,000 patients): low blood pressure, puffy face, diabetes, leg cramps, back pain, kidney problems, nerve damage, bleeding gums, aplastic anaemia.
sťo Zelo redko opisani neželeni učinki (pri manj kot 1 na vsakih 10. 000 bolnikov): nizek krvni tlak, zabuhel obraz, sladkorna bolezen, krči v nogah, bolečine v hrbtu, težave z ledvicami, poškodbe živcev, krvavitev iz dlesni, aplastična anemija.
Pure red cell aplasia, a condition where the body stopped or reduced the production
Ta motnja no povzroči hudo anemijo, med njene simptome pa sodijo neobičajna utrujenost in pomanjkanje energije.
This causes severe anaemia, symptoms of which would include unusual tiredness and a lack of energy.
Zelo redko so poročali o sarkoidozi (bolezni, za katero je značilna trdovratna zvišana temperatura, lat
Very rarely sarcoidosis, (a disease characterised by persistent fever, weight loss, joint pain and swelling, skin lesions and swollen glands) has been reported.
hujšanje, bolečine v sklepih in otekanje sklepov, kožne lezije in oteklost žlez).
Cases of stroke (cerebrovascular events) have been reported.
možganske kapi (cerebrovaskularni pojavi).
ed Periodontal (affecting gums) and dental disorders, altered mental status, loss of consciousness, acute hypersensitivity reactions including urticaria (hives), angioedema (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing), bronchoconstriction and
Poročali so tudi o periodontalni bolezni (prizadetost dlesni), zobnih boleznih, spremenjenem duševnem stanju, izgubi zavesti ter akutnih preobčutljivostnih reakcijah, vključno z urtikarijo (koprivnica), no
s anaphylaxis (a severe, whole-body allergic reaction) have been reported, but their frequency is unknown.
angioedemom (otekanje dlani, stopal, gležnjev, obraza, ustnic, ust ali žrela, ki lahko povzroči težave pri požiranju ali dihanju), bronhokonstrikcijo in anafilaksijo (huda alergijska reakcija po vsem telesu), vendar njihova pogostnost ni znana. če
ori Additionally, Vogt-Koyanagi-Harada syndrome (an autoimmune inflammatory disorder affecting the eyes, skin and the membranes of the ears, brain and spinal cord) has been reported with Viraferon use.
Poleg tega so pri uporabi zdravila Viraferon poročali tudi o pojavu sindroma Vogt- Koyanagi- Harada (avtoimunska vnetna bolezen, ki prizadene oči, kožo in ušesne membrane ter ovojnice možgan in hrbtenjače). on
uth Other side effects not listed above may also occur in some patients.
Pri nekaterih bolnikih se lahko pojavijo tudi drugi neželeni učinki, ki niso navedeni zgoraj.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, uk
ge Keep out of the reach and sight of children. lon Store in a refrigerator (2°C - 8°C).
Shranjujte v hladilniku (2 °C - 8 °C).
discarded.
Če zdravila v teh 4 tednih ne uporabite, ga morate zavreči.
The solution should be used immediately after reconstitution.
293 Raztopino morate uporabiti takoj po rekonstituciji.
If not used immediately, it must be stored at 2°C - 8°C in the refrigerator and used within 24 hours. t uc
Če raztopine ne uporabite takoj, jo morate shraniti v hladilniku pri temperaturi 2°C – 8°C in jo uporabiti v 24 urah.
Do not use Viraferon after the expiry date which is stated on the package. rod
Zdravila Viraferon ne smete uporabljajti po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
Do not use Viraferon if you notice changes in the appearance of Viraferon.
ie Ne uporabljajte zdravila Viraferon, če opazite spremembe videza zdravila Viraferon.
Any unused product must be discarded after withdrawal of the dose. lp
ác Neporabljeno zdravilo je potrebno zavreči potem, ko vzamete dmerek.
Ask your pharmacist how to dispose of medicines no longer required.
r zdravila, ki ga ne potrebujete več, se posvetujte s farmacevtom.
These measures will help to protect the environment. na
Takšni ukrepi pomagajo varovati okolje.
6.
ist 6.
FURTHER INFORMATION i dic
DODATNE INFORMACIJE
What Viraferon contains
eg Kaj vsebuje zdravilo Viraferon
- The active substance is recombinant interferon alfa-2b, 1 million IU/ ml.
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 1 milijon i. e. / ml.
- The other ingredients are glycine, disodium phosphate anhydrous, sodium dihydrogen phosphate
- Pomožne snovi so glicin, brezvodni natrijev hidrogenfosfat, natrijev dihidrogen fosfat monohidrat in
monohydrate, and human albumin solution.
raztopina humanega albumina.
- Solvent: water for injections 1 ml/ ampoule
- Vehikel: voda za injekcije 1 ml/ ampula.
Viraferon is presented as a powder and solvent for solution for injection The white to cream coloured powder is contained in a 2 ml glass vial and the clear and colourless solvent is presented in a 2 ml glass ampoule with 1 injection syringe, 2 injection needles and 1 cleansing swab.
Prašek bele do krem barve je v 2 ml stekleni viali, bister in brezbarven vehikel pa v 2 ml stekleni ampuli z 1 injekcijsko brizgo, 2 injekcijskima iglama in 1 čistilnim tamponom. lat
281 Not all pack sizes may be marketed.
Na trgu ni vseh navedenih pakiranj. up
SP Europe 73, rue de Stalle B-1180 Bruxelles Belgium
SP Europe 73, rue de Stalle B- 1180 Bruxelles no
ed For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika če
s ori België/ Belgique/ Belgien Rue de Stalle/ Stallestraat 73 B-1180 Bruxelles/ Brussel/ Brüssel
Luxembourg/ Luxemburg België/ Belgique/ Belgien on
Luxembourg/ Luxemburg Rue de Stalle 73 B-1180 Bruxelles/ Brüssel
Rue de Stalle 73 Rue de Stalle/ Stallestraat 73 B- 1180 Bruxelles/ Brüssel B- 1180 Bruxelles/ Brussel/ Brüssel Belgique/ Belgien Tél/ Tel: + 32 - (0) 2 370 92 11 uk
uth Tél/ Tel: + 32-(0)2 370 92 11
Tél/ Tel: + 32 - (0) 2 370 92 11
Belgique/ Belgien Tél/ Tel: + 32-(0)2 370 92 11
България ks
Милко Бичев "№ 7, ет .3 BG-София 1504
Милко Бичев "№ 7, ет. 3 BG- София 1504 Тел.: +359 2 944 1073 Lie
168 Christopher Street MT-VLT02 Valletta Tel: + 356-21 23 21 75
Malta Česká republika 168 Christopher Street Na Příkopě 25 MT- VLT02 Valletta CZ- 110 00 Praha 1 Tel: + 356- 21 23 21 75 Tel: +420 221771250
Nederland Maarssenbroeksedijk 4 NL-3542 DN Utrecht
294 Nederland Danmark Maarssenbroeksedijk 4 Lautrupbjerg 2 NL- 3542 DN Utrecht DK- 2750 Ballerup Tel: + 31 - (0) 800 778 78 78 Tlf: + 45- 44 39 50 00
398
ie Norge Deutschland Pb.
Tel: + 49-(0)89 627
398 Thomas- Dehler- Straße 27
31-0
ác N- 1326 Lysaker D- 81737 München Tlf: + 47 67 16 64 50 Tel: + 49 - (0) 89 627 31- 0
282 Eesti Österreich Järvevana tee 9 EE-11314 Tallinn Tel: + 372 654 96 86
r ist Österreich Eesti Badener Strasse 23 Järvevana tee 9 A- 2514 Traiskirchen EE- 11314 Tallinn
Badener Strasse 23 A-2514 Traiskirchen Tel: + 43-(0)2252 502-0
eg Tel: + 43 - (0) 2252 502- 0 Tel: + 372 654 96 86
Ελλάδα
Polska Ελλάδα
Polska
ur Al.
ed Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ: + 30-210 98 97 300
Jerozolimskie 195a Αγίου Δημητρίου 63 PL- 02- 222 Warszawa GR- 174 55 Άλιμος Tel.: + 48 - (0) 22 478 41 50 Tηλ.: + 30- 210 98 97 300
Jerozolim skie 195a PL-02-222 Warszawa Tel.: + 48-(0)22 478 41 50
sťo Portugal España Rua Agualva dos Açores 16 Km.
s ori España Km.
36, Ctra.
Nacional I E-28750 San Agustín de Guadalix – Madrid
Nacional I P- 2735- 557 Agualva- Cacém E- 28750 San Agustín de Guadalix – Madrid no Tel: +351- 21 433 93 00 Tel: + 34- 91 848 85 00
România
România France lat
17-21, Băneasa Center, et.
17- 21, 92 rue Baudin Băneasa Center, et.
8, sector 1 RO-013682 Bucureşti
8, sector 1 F- 92300 Levallois- Perret up
ge Tel. + 40 21 233 35 30 Ireland Shire Park
RO- 013682 Bucureşti Tél: + 33 - (0) 1 41 06 35 00 Tel: + 40 21 233 35 30
Slovenija Dunajska 22 lon
Slovenija Ireland no
Welwyn Garden City Hertfordshire AL7 1TW Tel: + 44-(0)1 707 363 636
Dunajska 22 Shire Park SI- 1000 Ljubljana Welwyn Garden City Tel: + 386 01 3001070 Hertfordshire AL7 1TW če
SI-1000 Ljubljana Tel. + 386 01 3001070 no
Tel: +44 - (0) 1 707 363 636
Slovenská republika Strakova 5 SK-811 01 Bratislava
Slovenská republika Ísland on
Tel: + 421 (2) 5920 2712
Strakova 5 Hörgatún 2 SK- 811 01 Bratislava IS- 210 Garðabær Tel: + 421 (2) 5920 2712 Sími: + 354 535 70 00 uk
Italia Via fratelli Cervi snc,
Italia Via fratelli Cervi snc, ks
Centro Direzionale Milano Palazzo Borromini I-20090 Segrate (Milano)
Centro Direzionale Milano Due Palazzo Borromini I- 20090 Segrate (Milano) Lie
Tel: + 39-02 21018.1
Tel: + 39- 02 21018. 1
Οδός Αγίου Νικολάου, 8 CY-1055 Λευκωσία Τηλ: + 357-22 757188 i dic
295 Sverige Κύπρος Box 6185 Οδός Αγίου Νικολάου, 8 S- 102 33 Stockholm CY- 1055 Λευκωσία Tel: + 46 - (0) 8 522 21 500 Τηλ: +357- 22 757188
Latvija Bauskas 58a -401 Me
ie United Kingdom Latvija Shire Park Bauskas 58a - 401
Rīga, LV-1004 Tel: + 371-7 21 38 25
ác Welwyn Garden City Rīga, LV- 1004 Hertfordshire AL7 1TW - UK Tel: + 371- 7 21 38 25
Welwyn Garden City Hertfordshire AL7 1TW - UK Tel: + 44-(0)1 707 363 636
r Tel: + 44 - (0) 1 707 363 636
283 Lietuva Kęstučio g.
ist Lietuva Kęstučio g.
65/40 LT-08124 Vilniu s Tel. + 370 52 101868
eg LT- 08124 Vilnius Tel. + 370 52 101868
ed This leaflet was last approved on
ur Navodilo je bilo odobreno
s ori Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/
sťo Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /. no lat up no če on uk ks Lie
284 HOW TO SELF INJECT VIRAFERON
296 KAKO SI SAMI INJICIRATE ZDRAVILO VIRAFERON
Do not attempt to inject yourself unless you are sure you understand the procedure and requirement of self - injection.
Zdravila pa si ne skušajte injicirati, če niste prepričani, da razumete postopek in zahteve za
ed Preparation Collect nece ssary items before you begin:
ie samoinjiciranje.
- a vial of Viraferon powder for injection;
ác Priprava Preden začnete, si pripravite vse potrebne pripomočke:
- an ampoule of solvent for Viraferon (water for injections 1 ml);
- vialo zdravila Viraferon prašek za injiciranje;
- a long needle (for example 0.8 × 40 mm [21 gauge 1.5 inch]) to be used to add water for injections to
dolgo iglo (na primer 0, 8 × 40 mm [vel.
the Viraferon powder vial;
21, 1, 5 inča (palca, 1 palec=2, 54cm) inča (palca, 1
uth
-
- a short needle (for example 0.3 × 13 mm [30 gauge 0.5 inch]) for the subcutaneous injection;
eg palec=2, 54cm) (palca, 1 palec=2, 54cm)]), ki jo boste uporabili za dodajanje vode za injekcije v vialo s praškom zdravila Viraferon; kratko iglo (na primer 0, 3 × 13 mm [vel.
ra Reconstituting Viraferon powder for injection Remove the protective cap from the Viraferon vial.
sťo Rekonstitucija zdravila Viraferon prašek za injiciranje Snemite zaščitno kapico z viale zdravila Viraferon.
Do not touch the tip of the syringe.
Tega lahko shranite, da si boste z njim očistili tudi predel kože, kamor boste injicirali odmerek zdravila. no Vzemite brizgo iz ovojnine, pri tem pa se ne smete dotakniti vrha brizge.
Remove the needle guard without touching the needle and keep the syringe with the needle in your lon hand.
Snemite zaščitni pokrovček igle, ne da bi se dotaknili igle, in držite brizgo z iglo lat trdno v rokah.
Insert the needle in the ampoule of solvent and withdraw the total amount of solvent. no
Vstavite iglo v ampulo s topilom in posesajte celotno količino topila. up
To prepare the Viraferon solution insert the needle through the rubber top of the Viraferon vial and gently place the needle tip against the glass wall of the vial without touching the cleaned top of the vial with your hands. t
Za pripravo raztopine zdravila Viraferon vbodite iglo skozi gumijasti vrh viale z zdravilom Viraferon in previdno naslonite vrh igle na stekleno steno viale, ne da bi se pri tem z rokami dotaknili očiščenega vrha viale.
Slowly inject the diluent, aiming the stream of liquid at the glass wall of the vial in order to avoid production uc
Počasi injicirajte topilo v vialo, curek tekočine pa usmerite proti stekleni steni viale, da preprečite no
of air bubbles.
nastajanje zračnih mehurčkov.
To dissolve the white contents, swirl the Viraferon vial with a gentle rotary motion leaving the syringe needle in the vial, until the contents are completely dissolved.
Da se bo bela vsebina viale zdravila Viraferon raztopila, le- to nežno obračajte, pri čemer naj igla z brizgo ostane v viali, dokler se vsebina viale popolnoma ne raztopi.
If air bubbles do form, wait until the solution has settled and rod
Če zračni mehurčki kljub vsemu nastanejo, počakajte, če
all bubbles have risen to the top of the solution and disappeared before withdrawing your dose from the vial.
da se raztopina posede in se vsi mehurčki dvignejo na vrh raztopine ter izginejo, šele potem lahko posesate odmerek zdravila iz viale.
If not used immediately, it must be stored at 2°C - 8°C in the refrigerator and used within 24 hours. lp
Če raztopine ne uporabite takoj, jo morate shraniti v hladilniku pri temperaturi 2°C – 8°C in jo uporabiti v 24 urah. on
Measuring the dose of Viraferon from the reconstituted powder for injection Turn the vial and the syringe upside down in one hand.
Merjenje odmerka zdravila Viraferon iz rekonstituranega praška za injiciranje uk
reconstituted solution.
Obrnite vialo in brizgo narobe in ju držite v eni roki.
Your other hand will be free to move the plunger.
Pazite, da bo vrh igle potopljen v rekonstituirani raztopini zdravila Viraferon, z drugo roko pa boste premikali bat brizge.
Hold the syringe with the needle in the vial pointing up, remove the syringe from the long needle leaving the i dic
Snemite brizgo z dolge igle, ki naj ostane v viali, ne da bi se ks
needle in the vial and without touching the tip of the syringe.
pri tem dotaknili vrha brizge.
If you see any bubbles, pull the plunger slightly back; tap the syringe gently, with the needle pointing up, until the bubbles disappear.
Če opazite kakšne mehurčke, potegnite bat nekoliko nazaj in nežno potrkajte po brizgi, pri čemer naj bo igla usmerjena navzgor, dokler Lie
needle guard and place the syringe with the needle on a flat surface.
Vrnite zaščitni pokrovček na iglo in odložite brizgo z iglo na ravno površino.
285 Injecting the solution Select the injection site.
297 Injiciranje raztopine Izberite si mesto, kamor boste injicirali zdravilo.
If you are exceptionally thin, use only the thigh or outer surface of the arm for injection.
Če ste izjemno suhi, uporabite le stegno ali zunanjo površino roke za
ed Cleanse and disinfect the skin where the injection is to be made.
ác Očistite in dezinficirajte si kožo na mestu, kjer boste injicirali zdravilo.
Insert the needle into the pinched skin at an angle of 45° to 90°.
r Snemite zaščitni pokrovček z igle.
Inject the solution by pushing the
Z eno roko oblikujte kožno gubo, in sicer tako, da kožo dvignete in
ori plunger all the way down gently.
ist stisnete med dva prsta, z drugo pa držite brizgo kot svinčnik.
Pull the needle straight out of the skin.
Vbodite iglo v kožno gubo pod kotom 45° do 90°.
Press the injection site with a small bandage or sterile gauze if necessary for several seconds.
Injicirajte raztopino tako, da previdno potisnete bat do konca.
Do not massage the injection site.
Iglo potegnite naravnost iz kože.
If there is bleeding, cover with an adhesive
Po potrebi pritisnite na mesto injiciranja z majhno obvezo ali sterilno
uth bandage.
eg gazo za nekaj sekund.
The vial, ampoule and injection materials intended for single use must be discarded.
Če pride do krvavitve, pokrijte mesto s samolepilnim obližem.
Dispose of the syringe and needles safely in a closed container.
Vialo, ampulo in pripomočke za injiciranje, ki so namenjeni za enkratno uporabo, morate zavreči.
ra ge lon
Brizgo
rod
ur in igle zavrzite varno, v zaprti posodi.
lp
sťo no lat up no če on uk ks Lie
INFORMATION FOR THE USER
298 NAVODILO ZA UPORABO
Viraferon, 3 million IU/ml powder and solvent for solution for injection Interferon alfa -2b
Viraferon 3 milijoni i. e. / ml prašek in vehikel za raztopino za injiciranje interferon alfa- 2b
if their symptoms are the same as yours.
r škodovalo, čeprav imajo znake bolezni, podobne vašim.
s
ist
uth 1.
ur 2.
What Viraferon is and what it is used for 2.
Kaj morate vedeti, preden boste vzeli zdravilo Viraferon 3.
Before you use Vi raferon 3.
Kako uporabljati zdravilo Viraferon 4.
How to use Viraferon
Možni neželeni učinki
Further information
KAJ JE ZDRAVILO VIRAFERON IN ZA KAJ GA UPORABLJAMO
WHAT VIRAFERON IS AND WHAT IT IS USED FOR lon Viraferon (interferon alfa-2b) modifies the response of the body's immune system to help fight infections and severe d iseases.
Zdravilo Viraferon (interferon alfa- 2b) spremeni imunski odziv telesa in pomaga pri obrambi proti okužbam lat
Viraferon is used in adult patients for the treatment of chronic hepatitis B or C, which are viral infections of the liver. no
Viraferon se uporablja za zdravljenje odraslih bolnikov kroničnega hepatitisa B ali C, ki sta virusni okužbi jeter. up
- if you have hepatitis and have been treated recently with medications that suppress the immune system
- če imate hepatitis in ste se nedavno zdravili z zdravili, ki zavirajo imunski sistem (razen kratkotrajnega
(other than short -term treatment with cortisone-type medicine).
zdravljenja z zdravili, kot je kortizon).
- if you have a history of autoimmune disease, or have had an organ transplant and are taking medicine that
- če ste imeli kdaj v preteklosti avtoimunsko bolezen ali presaditev organa in jemljete zdravila, ki
Children and adolescents:
Lie
The use of interferon alfa -2b in children and
Uporaba interferona alfa- 2b